Fas receptor

The FAS receptor (FasR), also known as apoptosis antigen 1 (APO-1 or APT), cluster of differentiation 95 (CD95) or tumor necrosis factor receptor superfamily member 6 (TNFRSF6) is a is_associated_with::protein that in humans is encoded by the TNFRSF6 is_associated_with::gene.

The Fas receptor is a death receptor on the surface of cells that leads to programmed cell death (is_associated_with::apoptosis). It is one of two apoptosis pathways, the other being the mitochondrial pathway. FasR is located on is_associated_with::chromosome 10 in humans and 19 in mice. Similar sequences related by evolution (is_associated_with::orthologs) are found in most is_associated_with::mammals.

Gene
FAS receptor is located on the long arm of is_associated_with::chromosome 10 (10q24.1) in humans and on chromosome 19 in mice. The gene lies on the plus (Watson strand) and is 25,255 bases in length organised into 9 protein encoding is_associated_with::exons.

Protein
Previous reports have identified as many as eight splice variants, which are translated into seven is_associated_with::isoforms of the protein. Apoptosis-inducing Fas receptor is dubbed isoform 1 and is a type 1 is_associated_with::transmembrane protein. Many of the other isoforms are rare is_associated_with::haplotypes that are usually associated with a state of disease. However, two isoforms, the apoptosis-inducing membrane-bound form and the soluble form, are normal products whose production via is_associated_with::alternative splicing is regulated by the cytotoxic protein is_associated_with::TIA1.

The mature Fas protein has 319 amino acids, has a predicted molecular weight of 48 kiloDaltons and is divided into 3 domains: an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain has 157 amino acids and is rich in cysteine residues. The transmembrane and cytoplasmic domains have 17 and 145 amino acids respectively. Exons 1 through 5 encode the extracelluar region. Exon 6 encodes the transmembrane region. Exons 7-9 encode the intracellular region.

Function
Fas forms the is_associated_with::death-inducing signaling complex (DISC) upon ligand binding. Membrane-anchored is_associated_with::Fas ligand trimer on the surface of an adjacent cell causes oligomerization of Fas. Recent studies which suggested the trimerization of Fas could not be validated. Other models suggested the oligomerization up to 5-7 Fas molecules in the DISC. This event is also mimicked by binding of an agonistic Fas antibody, though some evidence suggests that the apoptotic signal induced by the antibody is unreliable in the study of Fas signaling. To this end, several clever ways of trimerizing the antibody for in vitro research have been employed.

Upon ensuing death domain (DD) aggregation, the receptor complex is internalized via the cellular endosomal machinery. This allows the adaptor molecule is_associated_with::FADD to bind the death domain of Fas through its own death domain.

FADD also contains a is_associated_with::death effector domain (DED) near its amino terminus, which facilitates binding to the DED of FADD-like interleukin-1 beta-converting enzyme (FLICE), more commonly referred to as is_associated_with::caspase-8. FLICE can then self-activate through is_associated_with::proteolytic cleavage into p10 and p18 subunits, two each of which form the active heterotetramer enzyme. Active caspase-8 is then released from the DISC into the cytosol, where it cleaves other effector caspases, eventually leading to DNA degradation, membrane blebbing, and other hallmarks of apoptosis.

Recently, Fas has also been shown to promote tumor growth, since during tumor progression, it is frequently downregulated or cells are rendered apoptosis resistant. Cancer cells in general, regardless of their Fas apoptosis sensitivity, depend on constitutive activity of Fas. This is stimulated by cancer-produced Fas ligand for optimal growth.

Although Fas has been shown to promote tumor growth in the above mouse models, analysis of the human cancer genomics database revealed that FAS is not significantly focally amplified across a dataset of 3131 tumors (FAS is not an oncogene), but is significantly focally deleted across the entire dataset of these 3131 tumors, suggesting that FAS functions as a tumor suppressor in humans.

In cultured cells, FasL induces various types of cancer cell apoptosis through the Fas receptor. In AOM-DSS-induced colon carcinoma and MCA-induced sarcoma mouse models, it has been shown that Fas acts as a tumor suppressor. Furthermore, the Fas receptor also mediates tumor-specific cytotoxic T lymphocyte (CTL) anti-tumor cytotoxicity.

Role in apoptosis
Some reports have suggested that the extrinsic Fas pathway is sufficient to induce complete is_associated_with::apoptosis in certain cell types through DISC assembly and subsequent caspase-8 activation.

These cells are dubbed Type 1 cells and are characterized by the inability of anti-apoptotic members of the Bcl-2 family (namely Bcl-2 and Bcl-xL) to protect from Fas-mediated apoptosis.

Characterized Type 1 cells include H9, CH1, SKW6.4 and SW480, all of which are lymphocyte lineages except the latter, which is a colon adenocarcinoma lineage.

However, evidence for is_associated_with::crosstalk between the extrinsic and intrinsic pathways exists in the Fas signal cascade.

In most cell types, caspase-8 catalyzes the cleavage of the pro-apoptotic BH3-only protein Bid into its truncated form, tBid. BH-3 only members of the Bcl-2 family exclusively engage anti-apoptotic members of the family (is_associated_with::Bcl-2, is_associated_with::Bcl-xL), allowing Bak and Bax to translocate to the outer mitochondrial membrane, thus permeabilizing it and facilitating release of pro-apoptotic proteins such as is_associated_with::cytochrome c and Smac/DIABLO, an antagonist of inhibitors of apoptosis proteins (IAPs).

Interactions
Fas receptor has been shown to interact with:
 * is_associated_with::Caspase 8,
 * is_associated_with::Caspase 10,
 * is_associated_with::CFLAR,
 * is_associated_with::FADD,
 * is_associated_with::Fas ligand,
 * is_associated_with::PDCD6, and
 * is_associated_with::Small ubiquitin-related modifier 1.